Board meeting on November 02, 2026 to consider and approve unaudited results for Q2 and H1 of FY27
Krsnaa Diagnostics has scheduled a Board of Directors meeting for Monday, November 02, 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Monday, November 02, 2026
- Results Period
- quarter and half year ended September 30, 2026
- Results Type
- unaudited standalone and consolidated financial results
Board meeting set for early November
Krsnaa Diagnostics has informed both BSE (Scrip Code: 543328) and NSE (Symbol: KRSNAA) that a meeting of its Board of Directors is scheduled to be held on Monday, November 02, 2026.
What the board will take up
- To consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2026
- To consider and approve the unaudited consolidated financial results for the same period
The notice is an advance intimation under Regulation 29(1) and (2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which requires listed companies to tell the exchanges in advance when a board meeting will consider financial results.
Why this matters to a retail investor
- The September quarter (Q2) and the April-to-September half year are the second reporting stretch of the financial year.
- The results will show how the company's diagnostic testing and imaging business performed in that period, on both a standalone and a consolidated basis.
- "Standalone" reflects the company on its own; "consolidated" includes its subsidiaries and is the fuller picture of the group.
- The numbers approved at this meeting are described as unaudited.
What to note
- This is a notice of a meeting, not the results themselves. The figures will come when the board approves them.
- The company has said the intimation is also being uploaded on its investor website.
- The update carries no financial figures, so there is nothing quantitative here to compare against past performance yet.
What to watch for
The key things to look at once the results are out are the company's revenue and profit for the quarter and half year, and how the consolidated numbers compare with the standalone ones. This notice only fixes the date on which those numbers are expected to be considered and approved.
Also from Krsnaa Diagnostics
Krsnaa Diagnostics to host Q2 & H1 FY27 earnings call on November 3, 2026 at 12:30 PM IST
27 Oct 2026
Krsnaa Diagnostics to Evaluate AZmed's AZtrauma AI for X-ray Fracture Triage
22 Oct 2026
Krsnaa Diagnostics Ltd promoter buys 4.62% stake, holding rises to 25.08%
16 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.